Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Gillanders, M.D.
Washington University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington University School of Medicine
St Louis, Missouri, United States
Eric Knoche, M.D.Feng Gao, M.D., Ph.D., MPHGeorge Ansstas, M.D.Jeffrey Ward, M.D., Ph.D.Joel Picus, M.D.Malachi Griffith, Ph.D.Melissa Reimers, M.D.Obi Griffith, Ph.D.Patrick Grierson, M.D.Peter Oppelt, M.D.Ramon Jin, M.D.Robert Schreiber, Ph.D.William Gillanders, M.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Mar 2025
- Primary completion
- 31 Jan 2030
- Completion
- 30 Jun 2034
- Last update posted
- 9 Jul 2026
- Registered enrollment
- 64
- Registry id
- NCT06529822
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.